Jordan S. Pober, M.D., Ph.D., recently appointed as the inaugural Bayer Professor of Translational Medicine, is an authority on the interrelations of vascular endothelial cells (which form the lining of blood vessels), inflammation, and immunity. His research aims to advance organ replacement therapy, tissue engineering, and regeneration of injured tissues.

Bayer, a global enterprise in the fields of health care, nutrition, and high-tech materials, established the professorship to recognize its shared goals with the School of Medicine: to improve and speed up the translation and delivery of fundamental scientific discoveries in human health, from the laboratory into the clinic; and to engage in innovative and collaborative research, with the broader goal to deliver improved patient care.

Pober is director of the medical school’s Human and Translational Immunology Program and vice-chair of the Department of Immunobiology. He earned his M.D. at the School of Medicine in 1977 along with a Ph.D. in molecular biophysics and biochemistry. He returned to Yale in 1991 as professor of pathology and immunobiology, and became professor of dermatology in 1998.

Pober founded the Vascular Biology and Transplantation Program, the medical school’s first interdisciplinary program in translational medicine, in 1999. He has been honored as a Searle Scholar, an Established Investigator of the American Heart Association, and a MERIT awardee of the National Heart, Lung, and Blood Institute.